Equities

Avacta Group PLC

AVCT:LSE

Avacta Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)43.20
  • Today's Change-0.05 / -0.12%
  • Shares traded1.74m
  • 1 Year change-60.00%
  • Beta1.7787
Data delayed at least 20 minutes, as of May 20 2024 17:07 BST.
More ▼
DateOpenHighLowCloseVolume
Monday, May 20, 2024Mon, May 20, 202443.2544.0042.2943.201,676,3431.68m
Friday, May 17, 2024Fri, May 17, 202443.5044.0042.0043.251,341,5861.34m
Thursday, May 16, 2024Thu, May 16, 202444.2544.2043.0043.501,525,3471.53m
Wednesday, May 15, 2024Wed, May 15, 202444.7544.8543.0044.251,450,8671.45m
Tuesday, May 14, 2024Tue, May 14, 202444.5044.9043.5044.751,115,5471.12m
Monday, May 13, 2024Mon, May 13, 202445.5046.0044.3044.301,075,8411.08m
Friday, May 10, 2024Fri, May 10, 202444.0046.0043.0045.503,363,1723.36m
Thursday, May 09, 2024Thu, May 09, 202445.2545.6043.0043.002,035,2362.04m
Wednesday, May 08, 2024Wed, May 08, 202444.7545.5044.0044.703,316,2713.32m
Tuesday, May 07, 2024Tue, May 07, 202445.5046.5044.0145.103,413,1133.41m
Friday, May 03, 2024Fri, May 03, 202446.5046.5044.5645.504,092,3574.09m
Thursday, May 02, 2024Thu, May 02, 202445.7547.0045.0046.502,722,3742.72m
Wednesday, May 01, 2024Wed, May 01, 202445.5046.7544.0046.752,525,4932.53m
Tuesday, April 30, 2024Tue, Apr 30, 202450.5050.9845.1845.755,582,2725.58m
Monday, April 29, 2024Mon, Apr 29, 202449.0050.2548.0048.303,024,2603.02m
Friday, April 26, 2024Fri, Apr 26, 202445.0049.4044.6848.805,616,4645.62m
Thursday, April 25, 2024Thu, Apr 25, 202445.2545.5044.0045.002,876,5042.88m
Wednesday, April 24, 2024Wed, Apr 24, 202444.7546.0043.0045.304,197,5704.20m
Tuesday, April 23, 2024Tue, Apr 23, 202444.7545.8043.0044.504,370,1174.37m
Monday, April 22, 2024Mon, Apr 22, 202447.2549.0043.5544.606,076,6026.08m
Data delayed at least 20 minutes, as of May 20 2024 18:07 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.